--- title: "Webinar Replay: Developing Long-Acting Injectable Protein Therapeutics" id: "1900" type: "post" slug: "webinar-replay-developing-long-acting-injectable-protein-therapeutics" published_at: "2026-07-01T14:43:14+00:00" modified_at: "2026-07-02T10:54:00+00:00" url: "https://innocorepharma.com/news-events/webinar-replay-developing-long-acting-injectable-protein-therapeutics/" markdown_url: "https://innocorepharma.com/news-events/webinar-replay-developing-long-acting-injectable-protein-therapeutics.md" taxonomy_category: - "Latest News" - "Presentations" --- 01 July 2026 | Presentations # Webinar Replay: Developing Long-Acting Injectable Protein Therapeutics On 18 June, Innocore hosted the webinar **Developing Long-Acting Injectable Protein Therapeutics: Challenges, Strategies and Solutions.** We would like to thank everyone who joined us live. Your participation and the insightful questions you shared made it an engaging and valuable session. During the webinar, our speakers ([Rob Steendam](https://innocorepharma.com/company/people/rob-steendam/) & [Aiva Simaite](https://innocorepharma.com/company/people/aiva-simaite/) ) discussed the key challenges associated with developing long-acting injectable (LAI) protein therapeutics and shared practical strategies to address them. The session also included a product development case study, demonstrating how an integrated formulation and process development approach can support protein LAI development. If you were unable to attend, or if you would like to revisit the discussion, the webinar recording is now available on demand. Simply complete the form below with your email address to gain access to the recording. After submitting the form, you will be automatically redirected to the webinar. ## Access the webinar recording Please complete the form below to gain access to the webinar, **Developing Long-Acting Injectable Protein Therapeutics: Challenges, Strategies and Solutions.** Once you have submitted the form, you will be redirected to the webinar recording. Please enter your email address to gain access to our webinar section. "*" indicates required fields Related insights [26 July 2018 | Funding InnoCore and Merck enter global collaboration Merck and InnoCore Pharmaceuticals to Improve Patient Compliance with New Drug Delivery Technology. Read the full story](https://innocorepharma.com/news-events/innocore-and-merck-enter-global-collaboration/) [11 September 2020 | Funding Bill & Melinda Gates Foundation Grant Awarded InnoCore Pharmaceuticals has been awarded a grant by the Bill & Melinda Gates Foundation to develop a long-acting injectable contraceptive implant. Read the full story](https://innocorepharma.com/news-events/innocore-awarded-grant-by-the-bill-melinda-gates-foundation-in-contraception/) [01 January 2021 | Funding InnoCore leads Consortium in Influenza vaccines InnoCore Pharmaceuticals has secured funding from the European Regional Development Fund to develop a biodegradable polymer-based microneedle array patch. Read the full story](https://innocorepharma.com/news-events/innocore-leads-consortium-in-influenza-vaccines/)